Developing the A-FLUX Reducer System, a coronary sinus implant that narrows the vessel to raise myocardial perfusion in coronary microvascular dysfunction. The SERRA-I early feasibility study plans 30 subjects across six sites.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
No Spam. Unsubscribe anytime.